EUR 3.56
(-0.89%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 3.15 Billion | 2.42 Billion | 1.98 Billion | 1.66 Billion | 1.71 Billion |
Cost of Revenue | 2.25 Billion | 1.71 Billion | 1.38 Billion | 1.17 Billion | 1.08 Billion |
Gross Profit | 890.9 Million | 707.1 Million | 602.9 Million | 486.7 Million | 621.98 Million |
Operating Expenses | 603.3 Million | 499 Million | 451.6 Million | 351.5 Million | 486.92 Million |
Selling, General and Administrative Expenses | - | 471.4 Million | 424.9 Million | 327.3 Million | - |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 603.3 Million | -27.6 Million | -26.7 Million | -24.2 Million | 486.92 Million |
Cost and Expenses | 2.86 Billion | 2.21 Billion | 1.83 Billion | 1.52 Billion | 1.57 Billion |
Operating Income | 287.6 Million | 208.1 Million | 151.3 Million | 135.2 Million | 134.46 Million |
Interest Expense | 35.8 Million | 12.2 Million | 9.1 Million | 10.9 Million | 8.04 Million |
Income Tax Expense | 62.4 Million | 39.5 Million | 29.1 Million | 35.2 Million | 36.78 Million |
Earnings before Tax | 254.9 Million | 175.1 Million | 167.3 Million | 133.19 Million | 125.79 Million |
Net Income | 191.2 Million | 140.3 Million | 136.5 Million | 96.7 Million | 89.01 Million |
Earnings Per Share Basic | 0.52 | 0.43 | 0.41 | 0.29 | 1.00 |
Earnings Per Share Diluted | 0.51 | 0.42 | 0.41 | 0.29 | 1.00 |
Weighted Average Shares Outstanding | 371.03 Million | 329.82 Million | 329.26 Million | 329.26 Million | 89.26 Million |
Weighted Average Shares Outstanding (Diluted) | 371.88 Million | 330.95 Million | 329.26 Million | 329.26 Million | 89.26 Million |
Gross Margin | 0.28 | 0.29 | 0.30 | 0.29 | 0.36 |
EBIT Margin | 0.13 | 0.12 | 0.11 | 0.13 | 0.12 |
Profit Margin | 0.06 | 0.06 | 0.07 | 0.06 | 0.05 |
EBITDA | 422.4 Million | 277.8 Million | 252.5 Million | 222.3 Million | 208.22 Million |
Earnings Before Tax Margin | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | 1.27 Billion | - | 3.15 Billion | 1.59 Billion | 1.55 Billion | 1.26 Billion |
Cost of Revenue | 1.22 Billion | - | 2.25 Billion | 1.17 Billion | 1.08 Billion | 898.8 Million |
Gross Profit | 51 Million | - | 890.9 Million | 423.6 Million | 467.3 Million | 363.7 Million |
Operating Expenses | 54.6 Million | - | 603.3 Million | 282 Million | 321.7 Million | 253.1 Million |
Selling, General and Administrative Expenses | 53 Million | - | - | 242.6 Million | 297.5 Million | 238.5 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -1.6 Million | - | -79.09 Million | -39.4 Million | -24.2 Million | -14.6 Million |
Cost and Expenses | 1.27 Billion | - | 2.86 Billion | 1.45 Billion | 1.4 Billion | 1.15 Billion |
Operating Income | -3.6 Million | - | 287.6 Million | 141.6 Million | 145.6 Million | 110.6 Million |
Interest Expense | 24.4 Million | - | 35.8 Million | 20.5 Million | 15.6 Million | 7.6 Million |
Income Tax Expense | 3 Million | - | 62.4 Million | 28.4 Million | 34 Million | 19.7 Million |
Earnings before Tax | -29 Million | - | 254.9 Million | 118.5 Million | 136.4 Million | 93.9 Million |
Net Income | -31.9 Million | - | 191.2 Million | 89.6 Million | 101.6 Million | 73.9 Million |
Earnings Per Share Basic | -0.09 | 0.03 | - | 0.24 | 0.27 | 0.22 |
Earnings Per Share Diluted | -0.09 | 0.03 | - | 0.24 | 0.27 | 0.22 |
Weighted Average Shares Outstanding | 350.54 Million | 370.36 Million | 371.03 Million | 370.61 Million | 371.39 Million | 329.68 Million |
Weighted Average Shares Outstanding (Diluted) | 350.54 Million | 370.36 Million | 371.88 Million | 371.65 Million | 372.08 Million | 330.92 Million |
Gross Margin | 0.04 | - | 0.28 | 0.27 | 0.30 | 0.29 |
EBIT Margin | 0.05 | - | - | 0.14 | 0.13 | 0.12 |
Profit Margin | -0.03 | - | 0.06 | 0.06 | 0.07 | 0.06 |
EBITDA | 64.4 Million | - | - | 216.9 Million | 201.7 Million | 156.3 Million |
Earnings Before Tax Margin | -0.00 | - | 0.09 | 0.09 | 0.09 | 0.09 |
MRUS
4093
RELINFRA
MEDCL
HMS
7417